Annual CFF
$270.15 M
+$235.40 M+677.35%
December 31, 2024
Summary
- As of March 12, 2025, RLAY annual cash flow from financing activities is $270.15 million, with the most recent change of +$235.40 million (+677.35%) on December 31, 2024.
- During the last 3 years, RLAY annual CFF has fallen by -$117.94 million (-30.39%).
- RLAY annual CFF is now -36.66% below its all-time high of $426.51 million, reached on December 31, 2020.
Performance
RLAY Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$800.00 K
-$218.09 M-99.63%
December 31, 2024
Summary
- As of March 12, 2025, RLAY quarterly cash flow from financing activities is $800.00 thousand, with the most recent change of -$218.09 million (-99.63%) on December 31, 2024.
- Over the past year, RLAY quarterly CFF has dropped by -$742.00 thousand (-48.12%).
- RLAY quarterly CFF is now -99.81% below its all-time high of $426.19 million, reached on September 30, 2020.
Performance
RLAY Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$270.15 M
-$21.12 M-7.25%
December 31, 2024
Summary
- As of March 12, 2025, RLAY TTM cash flow from financing activities is $270.15 million, with the most recent change of -$21.12 million (-7.25%) on December 31, 2024.
- Over the past year, RLAY TTM CFF has increased by +$188.31 million (+230.10%).
- RLAY TTM CFF is now -59.84% below its all-time high of $672.76 million, reached on September 30, 2022.
Performance
RLAY TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RLAY Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +677.4% | -48.1% | +230.1% |
| 3 y3 years | -30.4% | -99.8% | -30.4% |
| 5 y5 years | +4719.0% | +452.4% | +4719.0% |
RLAY Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -30.4% | +677.4% | -99.8% | at low | -59.8% | +1829.5% |
| 5 y | 5-year | -36.7% | +4719.0% | -99.8% | +452.4% | -59.8% | >+9999.0% |
| alltime | all time | -36.7% | +4719.0% | -99.8% | +452.4% | -59.8% | >+9999.0% |
Relay Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $270.15 M(+677.4%) | $800.00 K(-99.6%) | $270.15 M(-7.3%) |
| Sep 2024 | - | $218.89 M(>+9900.0%) | $291.27 M(+255.9%) |
| Jun 2024 | - | $1.54 M(-96.8%) | $81.84 M(-0.7%) |
| Mar 2024 | - | $48.92 M(+123.2%) | $82.38 M(+137.0%) |
| Dec 2023 | $34.75 M(-88.0%) | $21.92 M(+131.7%) | $34.75 M(+148.2%) |
| Sep 2023 | - | $9.46 M(+354.7%) | $14.00 M(-95.2%) |
| Jun 2023 | - | $2.08 M(+60.4%) | $290.41 M(+0.0%) |
| Mar 2023 | - | $1.30 M(+11.2%) | $290.32 M(+0.1%) |
| Dec 2022 | $289.91 M(-25.3%) | $1.17 M(-99.6%) | $289.91 M(-56.9%) |
| Sep 2022 | - | $285.87 M(>+9900.0%) | $672.76 M(+73.5%) |
| Jun 2022 | - | $2.00 M(+126.0%) | $387.79 M(+0.2%) |
| Mar 2022 | - | $883.00 K(-99.8%) | $386.92 M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $388.09 M(-9.0%) | $384.01 M(>+9900.0%) | $388.09 M(+9287.8%) |
| Sep 2021 | - | $902.00 K(-19.5%) | $4.13 M(-99.0%) |
| Jun 2021 | - | $1.12 M(-45.5%) | $429.43 M(+0.3%) |
| Mar 2021 | - | $2.06 M(+3569.6%) | $428.21 M(+0.4%) |
| Dec 2020 | $426.51 M(+7508.1%) | $56.00 K(-100.0%) | $426.51 M(+0.1%) |
| Sep 2020 | - | $426.19 M(<-9900.0%) | $426.23 M(>+9900.0%) |
| Jun 2020 | - | -$93.00 K(-126.5%) | $147.00 K(-83.8%) |
| Mar 2020 | - | $351.00 K(-254.6%) | $910.00 K(-83.8%) |
| Dec 2019 | $5.61 M(-98.6%) | -$227.00 K(-295.7%) | $5.61 M(-3.9%) |
| Sep 2019 | - | $116.00 K(-82.7%) | $5.83 M(+2.0%) |
| Jun 2019 | - | $670.00 K(-86.7%) | $5.72 M(+13.3%) |
| Mar 2019 | - | $5.05 M | $5.05 M |
| Dec 2018 | $394.97 M | - | - |
FAQ
- What is Relay Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Relay Therapeutics?
- What is Relay Therapeutics annual CFF year-on-year change?
- What is Relay Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Relay Therapeutics?
- What is Relay Therapeutics quarterly CFF year-on-year change?
- What is Relay Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Relay Therapeutics?
- What is Relay Therapeutics TTM CFF year-on-year change?
What is Relay Therapeutics annual cash flow from financing activities?
The current annual CFF of RLAY is $270.15 M
What is the all time high annual CFF for Relay Therapeutics?
Relay Therapeutics all-time high annual cash flow from financing activities is $426.51 M
What is Relay Therapeutics annual CFF year-on-year change?
Over the past year, RLAY annual cash flow from financing activities has changed by +$235.40 M (+677.35%)
What is Relay Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of RLAY is $800.00 K
What is the all time high quarterly CFF for Relay Therapeutics?
Relay Therapeutics all-time high quarterly cash flow from financing activities is $426.19 M
What is Relay Therapeutics quarterly CFF year-on-year change?
Over the past year, RLAY quarterly cash flow from financing activities has changed by -$742.00 K (-48.12%)
What is Relay Therapeutics TTM cash flow from financing activities?
The current TTM CFF of RLAY is $270.15 M
What is the all time high TTM CFF for Relay Therapeutics?
Relay Therapeutics all-time high TTM cash flow from financing activities is $672.76 M
What is Relay Therapeutics TTM CFF year-on-year change?
Over the past year, RLAY TTM cash flow from financing activities has changed by +$188.31 M (+230.10%)